Table 1.
Demographic and clinical characteristics of patients and control in Part I study: Monotherapy with ezetimibe
| Parameter | Ezetimibe (n = 16) | Control (n = 5) |
|---|---|---|
| Mean age (years) | 52.1 ± 4.9 | 54.2 ± 5.3 |
| Gender: male/female | 12/4 | 3/2 |
| Mean systolic blood pressure (mmHg) | 120 ± 8 | 119 ± 8 |
| Mean diastolic blood pressure (mmHg) | 82 ± 5 | 80 ± 4 |
| Mean body mass index (kg m−2) | 25.7 ± 2 | 26.7 ± 0.9 |
| Coronary heart disease | 0 | 0 |
| Cerebrovascular disease | 0 | 0 |
| Diabetes mellitus | 0 | 0 |
| Hypertension | 11 | 0 |
| Smoker | 2 | 0 |
| Aspirin use | 9 | 0 |
| Angiotensin converting enzyme inhibitor | 5 | 0 |
| Calcium channel blockers | 2 | 0 |
| Angiotensin receptor blocker | 1 | 0 |
| Hormone replacement therapy | 0 | 0 |
| Diuretics | 3 | 0 |
| β-Blockers | 1 | 0 |